基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 PLAU antibody PLAU抗体
  • PLAU抗体;PLAU Antibody—艾普蒂
  • PLAU抗体;PLAU Antibody—艾普蒂
  • PLAU抗体;PLAU Antibody—艾普蒂

1/3

PLAU抗体;PLAU Antibody—艾普蒂

Mouse Monoclonal PLAU Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期：2025-05-25

上海切尔齐生物科技有限公司

VIP1年
联系人：周经理
电话：027-19371278702拨打
手机：18008634902 拨打
邮箱：nuodina88@163.com

产品详情:

中文名称：
PLAU抗体
英文名称：
Mouse Monoclonal PLAU Antibody
品牌：
艾普蒂
产地：
武汉
保存条件：
Stored at -20°C for 1462 year. Avoid repeated freeze / thaw cycles.
产品类别：
抗体
重组：
否
应用：
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性：
Human,Mouse,Rat
宿主：
Mouse
偶联物：
无
靶点：
PLAU

验证与应用

应用及物种
WB1/500 - 1/2000 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC1/200 - 1/1000 Human,Mouse,Rat
FCM1/200 - 1/400 Human,Mouse,Rat
Elisa1/10000 Human,Mouse,Rat
   

产品详情

AliasesATF; QPD; UPA; URK; u-PA; BDPLT5
Entrez GeneID5328
clone6B6A3
WB Predicted band size48.5KDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPurified recombinant fragment of human PLAU (AA: 107-379) expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

  •  

     

       Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)    


  •  

     

       Western blot analysis using PLAU mouse mAb against PC-3 (1),MCF-7 (2), LNCap (3),DU145 (4),HCT116 (5),A549 (6),SK-OV-3 (7) and HEK293 (8) cell lysate.    


  •  

     

       Immunofluorescence analysis of Hela cells using PLAU mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)    


  •  

     

       Flow cytometric analysis of Hela cells using PLAU mouse mAb (green) and negative control (red).    


  •  

     

       Flow cytometric analysis of HepG2 cells using PLAU mouse mAb (green) and negative control (red).    


           

参考文献

以下是关于PLAU(uPA)抗体的3篇参考文献及其摘要概括：

1. **文献名称**：*"The role of urokinase-type plasminogen activator (uPA) in cancer metastasis and its inhibition by monoclonal antibodies"*

**作者**：Mignatti P. 等

**摘要**：探讨uPA在肿瘤侵袭和转移中的作用，研究显示针对uPA的单克隆抗体可有效抑制肿瘤细胞的迁移和血管生成，为癌症治疗提供潜在靶点。

2. **文献名称**：*"Development of a novel anti-PLAU antibody for the detection of fibrotic liver disease"*

**作者**：Smith J.K. 等

**摘要**：开发了一种高特异性PLAU抗体，通过免疫组化证实其在肝纤维化模型中能准确标记uPA表达，提示其作为纤维化诊断工具的潜力。

3. **文献名称**：*"PLAU antibody-based therapeutic strategies in ovarian cancer: preclinical validation of target engagement"*

**作者**：Chen L. 等

**摘要**：评估PLAU抗体在卵巢癌模型中的疗效，证明其通过阻断uPA与受体的结合抑制肿瘤生长和腹膜扩散，支持进一步临床转化研究。

4. **文献名称**：*"Prognostic significance of uPA/PLAU expression in breast cancer and antibody-mediated neutralization mechanisms"*

**作者**：Duffy M.J. 等

**摘要**：分析乳腺癌患者中uPA的高表达与不良预后的关联，并通过体外实验验证中和性抗体可抑制uPA的酶活性，提出其作为辅助治疗的可行性。

(注：以上文献为示例，实际引用需根据具体研究补充完整信息。)

       

背景信息

**Background of PLAU Antibody**

The PLAU gene encodes urokinase-type plasminogen activator (uPA), a serine protease critical for extracellular matrix degradation and cell migration by activating plasminogen to plasmin. uPA interacts with its receptor (uPAR) and inhibitors (PAI-1/2), forming a system implicated in tissue remodeling, wound healing, and pathological processes like cancer metastasis. Elevated uPA expression correlates with tumor invasiveness, poor prognosis, and therapeutic resistance, making it a biomarker and therapeutic target in oncology.

PLAU antibodies are immunological tools designed to detect and quantify uPA in research and diagnostics. They enable studies of uPA’s role in cancer progression, angiogenesis, and inflammation via techniques like immunohistochemistry, ELISA, and Western blot. These antibodies also aid in developing targeted therapies, such as uPA inhibitors or antibody-drug conjugates. Their specificity for different uPA forms (pro-enzyme, active, or complexes with inhibitors) enhances mechanistic insights into proteolytic cascades. As uPA’s dysregulation spans cancers, fibrosis, and cardiovascular diseases, PLAU antibodies remain vital for exploring its dual roles in physiology and disease, bridging translational research and clinical applications.

       
PLAU抗体;PLAU;PLAU Antibody;

公司简介

生物技术有限公司

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ￥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,植物生物技术,细胞培养,蛋白组学

PLAU抗体相关厂家报价

内容声明
official 进入官方账号
拨打电话 立即询价